Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
Abstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible,...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0843-7 |
_version_ | 1828880749221117952 |
---|---|
author | Dan-ming Wei Wen-jie Chen Rong-mei Meng Na Zhao Xiang-yu Zhang Dan-yu Liao Gang Chen |
author_facet | Dan-ming Wei Wen-jie Chen Rong-mei Meng Na Zhao Xiang-yu Zhang Dan-yu Liao Gang Chen |
author_sort | Dan-ming Wei |
collection | DOAJ |
description | Abstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible, of which 96 studies reported on overall survival (OS) and 19 studies reported on disease-free survival (DFS) with relation to Ki-67 expression in lung cancer patients. Results The pooled hazard ratio (HR) indicated that a high Ki-67 level could be a valuable prognostic factor for lung cancer (HR = 1.122 for OS, P < 0.001 and HR = 1.894 for DFS, P < 0.001). Subsequently, the results revealed that a high Ki-67 level was significantly associated with clinical parameters of lung cancer including age (odd ratio, OR = 1.246 for older patients, P = 0.018), gender (OR = 1.874 for males, P < 0.001) and smoking status (OR = 3.087 for smokers, P < 0.001). Additionally, significant positive correlations were found between Ki-67 overexpression and poorer differentiation (OR = 1.993, P = 0.003), larger tumor size (OR = 1.436, P = 0.003), and higher pathologic stages (OR = 1.867 for III-IV, P < 0.001). Furthermore, high expression of Ki-67 was found to be a valuable predictive factor for lymph node metastasis positive (OR = 1.653, P < 0.001) and advanced TNM stages (OR = 1.497 for stage III-IV, P = 0.024). Finally, no publication bias was detected in any of the analyses. Conclusions This study highlights that the high expression of Ki-67 is clinically relevant in terms of the prognostic and clinicopathological characteristics for lung cancer. Nevertheless, more prospective well-designed studies are warranted to validate these findings. |
first_indexed | 2024-12-13T09:54:47Z |
format | Article |
id | doaj.art-e7b84b31c3554a51a6f82d45f316a349 |
institution | Directory Open Access Journal |
issn | 1465-993X |
language | English |
last_indexed | 2024-12-13T09:54:47Z |
publishDate | 2018-08-01 |
publisher | BMC |
record_format | Article |
series | Respiratory Research |
spelling | doaj.art-e7b84b31c3554a51a6f82d45f316a3492022-12-21T23:51:50ZengBMCRespiratory Research1465-993X2018-08-0119111910.1186/s12931-018-0843-7Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patientsDan-ming Wei0Wen-jie Chen1Rong-mei Meng2Na Zhao3Xiang-yu Zhang4Dan-yu Liao5Gang Chen6Department of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityDepartment of Pathology, First Affiliated Hospital of Guangxi Medical UniversityAbstract Background Lung cancer ranks as the leading cause of cancer-related deaths worldwide and we performed this meta-analysis to investigate eligible studies and determine the prognostic effect of Ki-67. Methods In total, 108 studies in 95 articles with 14,732 patients were found to be eligible, of which 96 studies reported on overall survival (OS) and 19 studies reported on disease-free survival (DFS) with relation to Ki-67 expression in lung cancer patients. Results The pooled hazard ratio (HR) indicated that a high Ki-67 level could be a valuable prognostic factor for lung cancer (HR = 1.122 for OS, P < 0.001 and HR = 1.894 for DFS, P < 0.001). Subsequently, the results revealed that a high Ki-67 level was significantly associated with clinical parameters of lung cancer including age (odd ratio, OR = 1.246 for older patients, P = 0.018), gender (OR = 1.874 for males, P < 0.001) and smoking status (OR = 3.087 for smokers, P < 0.001). Additionally, significant positive correlations were found between Ki-67 overexpression and poorer differentiation (OR = 1.993, P = 0.003), larger tumor size (OR = 1.436, P = 0.003), and higher pathologic stages (OR = 1.867 for III-IV, P < 0.001). Furthermore, high expression of Ki-67 was found to be a valuable predictive factor for lymph node metastasis positive (OR = 1.653, P < 0.001) and advanced TNM stages (OR = 1.497 for stage III-IV, P = 0.024). Finally, no publication bias was detected in any of the analyses. Conclusions This study highlights that the high expression of Ki-67 is clinically relevant in terms of the prognostic and clinicopathological characteristics for lung cancer. Nevertheless, more prospective well-designed studies are warranted to validate these findings.http://link.springer.com/article/10.1186/s12931-018-0843-7Ki-67Lung cancerMeta-analysisPrognosisClinicopathological characteristics |
spellingShingle | Dan-ming Wei Wen-jie Chen Rong-mei Meng Na Zhao Xiang-yu Zhang Dan-yu Liao Gang Chen Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients Respiratory Research Ki-67 Lung cancer Meta-analysis Prognosis Clinicopathological characteristics |
title | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients |
title_full | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients |
title_fullStr | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients |
title_full_unstemmed | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients |
title_short | Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients |
title_sort | augmented expression of ki 67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients an up dated systematic review and meta analysis with 108 studies and 14 732 patients |
topic | Ki-67 Lung cancer Meta-analysis Prognosis Clinicopathological characteristics |
url | http://link.springer.com/article/10.1186/s12931-018-0843-7 |
work_keys_str_mv | AT danmingwei augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT wenjiechen augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT rongmeimeng augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT nazhao augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT xiangyuzhang augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT danyuliao augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients AT gangchen augmentedexpressionofki67iscorrelatedwithclinicopathologicalcharacteristicsandprognosisforlungcancerpatientsanupdatedsystematicreviewandmetaanalysiswith108studiesand14732patients |